The Medical Advisor

In This Article: Introduction Chapter 1: Conventional, Standard Cancer Treatments and the Search for New Solutions Chapter 2: Repurposing Existing Drugs for Cancer Chapter 3: Ivermectin for Cancer Ivermectin Mechanisms of Action in Cancer Preclinical Evidence of Ivermectin (Cell and Animal Studies) Ivermectin Clinical Evidence and Anecdotal Reports Protocols and Dosing Strategies of Ivermectin Chapter 4: Fenbendazole or Mebendazole for Cancer Fenbendazole and Mebendazole Mechanisms of Action in Cancer Preclinical Evidence of Fenbendazole and Mebendazole (Cell and Animal Studies) Fenbendazole and Mebendazole Clinical Evidence and Anecdotal Reports Protocols and Dosing Strategies of Fenbendazole and Mebendazole Fenbendazole and Mebendazole Safety, Side Effects, and Toxicity Conclusion and Future Directions Introduction In 2016, Oklahoma businessman Joe Tippens was diagnosed with small-cell lung cancer, an aggressive form that had already metastasized to his pancreas, ...

A research group from Mexico investigated Ivermectin in Cancer. This is the first study that has tested as many as 28 Cancer types with Ivermectin.  Paper: 2020 (Juarez et al) - Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug.  Ivermectin was tested at 2mg/kg/day which translates to roughly 5uM in vitro concentration. The most sensitive cancer cell lines were: 1. Ovarian 2. Breast 3. Glioblastoma 4. Lung Cancer 5. Colon Cancer 6. Uterine SCC 7. hepatocellular 8. breast TNBC 9. Pancreatic 10. Endometrial. Least sensitive were: 1. osteosarcoma 2. gastric 3. melanoma  Although lymphoma and leukemia cell lines appear to be more resistant to Ivermectin, Ivermectin has a significant impact on those cells' ability to form colonies. So yes, Ivermectin is useful against BOTH lymphomas and leukemias.  Ivermectin also goes after CANCER STEM CELLS, which tend to be resistant to chemotherapy: ...